mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.06 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.06 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.06 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.06 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.06 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.06 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.06 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.09 |
0.06 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.081 |
0.07 |